| Dysregulated B cell function and disease pathogenesis in systemic sclerosis CF Beesley, NR Goldman, TE Taher, CP Denton, DJ Abraham, ... Frontiers in Immunology 13, 999008, 2023 | 9 | 2023 |
| P134 Developing a potential composite pharmacodynamic serum marker of skin severity in systemic sclerosis E Roblin, KEN Clark, C Beesley, VH Ong, CP Denton Rheumatology 63 (Supplement_1), keae163. 174, 2024 | | 2024 |
| OA26 Paired bulk and single cell analysis of transitional B cells in systemic sclerosis highlights defective peripheral tolerance C Beesley, N Goldman, D Abraham, C Denton, R Mageed, VH Ong Rheumatology 63 (Supplement_1), keae163. 026, 2024 | | 2024 |
| P135 Association of Serum Anti-Muscarinic 3 Antibodies with Gastrointestinal Disease in Systemic Sclerosis E Roblin, C Beesley, R Maclean, F Ahmed, C Murray, VH Ong, C Denton Rheumatology 63 (Supplement_1), keae163. 175, 2024 | | 2024 |
| Testing a candidate composite serum protein marker of skin severity in systemic sclerosis E Roblin, KEN Clark, C Beesley, VH Ong, CP Denton Rheumatology Advances in Practice 8 (2), rkae039, 2024 | | 2024 |
| P153 Rituximab and tocilizumab and their effect on lung disease progression in scleroderma: a retrospective cohort study at a single centre NR Goldman, A Tynan, C Beesley, R Mageed, C Denton, VH Ong Rheumatology 62 (Supplement_2), kead104. 194, 2023 | | 2023 |
| P157 Distinct differences in complement perturbation between scleroderma-related interstitial lung disease with and without emphysema C Beesley, A Cole, N Goldman, J Barnett, D Abraham, C Denton, ... Rheumatology 62 (Supplement_2), kead104. 198, 2023 | | 2023 |
| Distinct Differences in Complement Perturbation Between Scleroderma-related Interstitial Lung Disease with and Without Emphysema C Beesley, A Cole, N Goldman, O Oluwakorede, J Barnett, D Abraham, ... | | 2022 |
| Rituximab and Tocilizumab and Their Effect on Lung Disease Progression in Scleroderma. a Retrospective Cohort Study at a Single Centre N Goldman, A Tynan, S Shah, C Beesley, R Mageed, C Denton, V Ong | | 2022 |
